# Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

> **NCT00220649** · PHASE1 · COMPLETED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 25 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **DRUG:** gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin

## Key facts

- **NCT ID:** NCT00220649
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2009-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220649, "Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00220649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*